ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselRegeneron Switzerland GmbH
Regeneron Switzerland GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Regeneron Switzerland GmbH is a biopharmaceutical company that researches, develops, and commercializes medicines, including biologics and genetic medicines. It conducts clinical trials and maintains research and manufacturing activities to support its drug development pipeline.

AI-generated
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Regeneron Switzerland GmbH

Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
✓ Offered12
Prescription biopharmaceuticals
Regeneron-invented approved medicines for serious diseases across allergy, inflammation, cardiovascular and metabolic disease, neuroscience, oncology, ophthalmology and rare diseases; available in the U.S., Europe, Japan and worldwide.
Clinical development and drug pipeline
Development of investigational medicines through clinical testing, including early- to late-stage programs in multiple therapeutic areas and full clinical development processes.
Research and development
Data-driven research and development using genetics, biology and technology to discover new drug candidates, validate targets and pursue biologics, genetic medicines and cell therapies.
Antibody medicines
Discovery and development of monoclonal, bispecific and costimulatory antibodies, supported by proprietary antibody technologies and engineering capabilities.
Genetic medicines
Gene editing, gene silencing and gene therapy approaches developed as part of the company’s therapeutic toolbox and pipeline.
Cell therapies
Development of next-generation cell therapies, including T-cell-based approaches and combinations with proprietary antibodies and bispecifics.
Manufacturing of medicines
Manufacturing of investigational and approved medicines at scale, including process development, production for clinical trials and commercial supply.
Business development partnerships
Strategic collaborations, licensing agreements and development partnerships for technologies, therapeutic candidates, clinical collaborations and commercial activities.
Third-party research collaborations
Access to approved and pipeline medicines, proprietary models and technologies for preclinical studies, investigator-initiated studies and research collaborations.
Grants and funding
Corporate funding, educational grants, sponsorships, exhibits and support for nonprofit, medical, STEM and community organizations.
Regeneron Genetics Center
Large-scale human genomics research and genetic databases to understand genetic drivers of human health and disease and support target discovery.
Clinical trials
Clinical trials for investigational products, including study information and trial locator access for patients, caregivers and healthcare professionals.
Trust & reputation

ranQ Trust Score of Regeneron Switzerland GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Regeneron Switzerland GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Regeneron Switzerland GmbH scores 61.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.50.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Regeneron Switzerland GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Regeneron Switzerland GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Regeneron Switzerland GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Regeneron Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Regeneron Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Regeneron Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Regeneron Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Grosspeteranlage 29
4052 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-426.698.987
Founded
2023 · 3 years
Last commercial register change
September 1, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    LT
    LifeMine Therapeutics (Switzerland) GmbH
    Basel
    HM
    Heart-Based Medicine Foundation
    Basel
    US
    Urovant Sciences GmbH
    Basel
    VT
    Vaderis Therapeutics AG
    Basel
    AA
    ARTIDIS AG
    Basel
    CT
    ClearideBio Therapeutics AG
    Basel
    FM
    Friedrich Miescher Institute for Biomedical Research
    Basel
    NA
    NBE-Therapeutics AG
    Basel